These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9390209)

  • 1. Predictive factors for tumor response to systemic chemotherapy in patients with hepatocellular carcinoma.
    Nagahama H; Okada S; Okusaka T; Ishii H; Ikeda M; Nakasuka H; Yoshimori M
    Jpn J Clin Oncol; 1997 Oct; 27(5):321-4. PubMed ID: 9390209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy.
    Okada S; Okazaki N; Nose H; Yoshimori M; Aoki K
    Hepatology; 1992 Jul; 16(1):112-7. PubMed ID: 1377657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon Alfa-2b for treatment of hepatocellular carcinoma.
    Patt YZ; Hassan MM; Lozano RD; Brown TD; Vauthey JN; Curley SA; Ellis LM
    J Clin Oncol; 2003 Feb; 21(3):421-7. PubMed ID: 12560429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy in hepatocellular carcinoma.
    Okada S
    Hepatogastroenterology; 1998 Aug; 45 Suppl 3():1259-63. PubMed ID: 9730385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function.
    Yang H; Woo HY; Lee SK; Han JW; Jang B; Nam HC; Lee HL; Lee SW; Song DS; Song MJ; Oh JS; Chun HJ; Jang JW; Lozada A; Bae SH; Choi JY; Yoon SK
    Clin Mol Hepatol; 2017 Jun; 23(2):128-137. PubMed ID: 28494528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Identification of two groups of patients with prospects for prolonged survival.
    Ihde DC; Matthews MJ; Makuch RW; McIntire KR; Eddy JL; Seeff LB
    Am J Med; 1985 Mar; 78(3):399-406. PubMed ID: 2579551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic arterial infusion of 5-fluorouracil in combination with subcutaneous interferon-alpha for advanced hepatocellular carcinoma.
    Kuroda M; Kobayashi Y; Urawa N; Yamamoto M; Mifuji R; Araki J; Tanaka H; Horiike S; Itani T; Furjita N; Konishi M; Iwasa M; Kaito M; Adachi Y
    Hepatogastroenterology; 2007 Mar; 54(74):518-21. PubMed ID: 17523311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases.
    Ando E; Tanaka M; Yamashita F; Kuromatsu R; Yutani S; Fukumori K; Sumie S; Yano Y; Okuda K; Sata M
    Cancer; 2002 Aug; 95(3):588-95. PubMed ID: 12209752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon-alpha, doxorubicin and 5-fluorouracil chemotherapy.
    Leung TW; Tang AM; Zee B; Yu SC; Lai PB; Lau WY; Johnson PJ
    Cancer; 2002 Jan; 94(2):421-7. PubMed ID: 11905412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic chemotherapy for hepatocellular carcinoma in non-cirrhotic liver: a retrospective study.
    Edeline J; Raoul JL; Vauleon E; Guillygomac'h A; Boudjema K; Boucher E
    World J Gastroenterol; 2009 Feb; 15(6):713-6. PubMed ID: 19222095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The progress of hepatic arterial infusion chemotherapy for hepatocellular carcinoma].
    Noda T; Nagano H; Wada H; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Ohsuga K; Kim T; Tomoda K; Nakamura H; Monden M
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1221-5. PubMed ID: 16969014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrolamellar hepatocellular carcinoma in children and adolescents.
    Katzenstein HM; Krailo MD; Malogolowkin MH; Ortega JA; Qu W; Douglass EC; Feusner JH; Reynolds M; Quinn JJ; Newman K; Finegold MJ; Haas JE; Sensel MG; Castleberry RP; Bowman LC
    Cancer; 2003 Apr; 97(8):2006-12. PubMed ID: 12673731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Successful treatment for advanced hepatocellular carcinoma by hepatic arterial infusion of CDDP powder as second-line chemotherapy].
    Gen Y; Kimura H; Akitake R; Sakai A; Fukui A; Takao T; Ikezawa S; Masuda A; Takashima H; Funatsu E; Nakamura H; Okuyama Y; Arai M; Yagi N; Kutsumi H; Fujimoto S; Takeuchi Y
    Gan To Kagaku Ryoho; 2006 Apr; 33(4):505-8. PubMed ID: 16612162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular prediction of response to 5-fluorouracil and interferon-alpha combination chemotherapy in advanced hepatocellular carcinoma.
    Kurokawa Y; Matoba R; Nagano H; Sakon M; Takemasa I; Nakamori S; Dono K; Umeshita K; Ueno N; Ishii S; Kato K; Monden M
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6029-38. PubMed ID: 15447987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of sorafenib combined with low-dose interferon therapy for advanced hepatocellular carcinoma: a pilot study.
    Itokawa N; Atsukawa M; Tsubota A; Okubo T; Arai T; Nakagawa A; Kondo C; Iwakiri K
    Int J Clin Oncol; 2016 Aug; 21(4):676-683. PubMed ID: 26701173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of advanced hepatocellular carcinoma with lung metastases and cirrhosis that responded to combination chemotherapy with interferon-alpha and 5-fluorouracil].
    Shitara K; Munakata M; Kudo T; Muto O; Okada R; Mitobe S; Sakata Y; Kondo M; Ishii E; Yabu K
    Gan To Kagaku Ryoho; 2006 Dec; 33(13):2083-6. PubMed ID: 17197759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors of outcome and tumor response to systemic chemotherapy in patients with metastatic hepatocellular carcinoma.
    Ikeda M; Okusaka T; Ueno H; Morizane C; Kojima Y; Iwasa S; Hagihara A
    Jpn J Clin Oncol; 2008 Oct; 38(10):675-82. PubMed ID: 18716041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pilot study of intrahepatic arterial chemotherapy with methotrexate, 5-fluorouracil, cisplatin and subcutaneous interferon-alpha-2b for patients with locally advanced hepatocellular carcinoma.
    Urabe T; Kaneko S; Matsushita E; Unoura M; Kobayashi K
    Oncology; 1998; 55(1):39-47. PubMed ID: 9428374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel intrahepatic arterial chemotherapy after radical resection for advanced hepatocellular carcinoma.
    Tanaka S; Shimada M; Shirabe K; Maehara S; Harimoto N; Tsujita E; Sugimachi K; Maehara Y
    Hepatogastroenterology; 2005; 52(63):862-5. PubMed ID: 15966221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Decreases in α-Fetoprotein and Des-γ-carboxy Prothrombin Predict the Antitumor Effects of Hepatic Transarterial Infusion Chemotherapy with Cisplatin (CDDP) Powder in Patients with Advanced Hepatocellular Carcinoma.
    Hatanaka T; Kakizaki S; Shimada Y; Takizawa D; Katakai K; Yamazaki Y; Sato K; Kusano M; Yamada M
    Intern Med; 2016; 55(16):2163-71. PubMed ID: 27522991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.